Eton is seeking FDA approval for its ASN-001 product line, targeting NDA submission and launch.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eton is seeking FDA approval for its ASN-001 product line, targeting NDA submission and launch.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Data was presented in Athens supporting a future U.S. NDA submission to the FDA.
- Kowa's New Drug Application (NDA) for drug K-911 was accepted by the FDA for review.
- FDA clearance drives market expansion and coverage for NeurAxis, Inc.
- A product was launched in the U.S. market following FDA involvement.
- Mylan is seeking regulatory approval from the FDA for new products and has listed its stock on the Nasdaq exchange.